Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap.
Saved in:
| Title: | Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap. |
|---|---|
| Authors: | van Riet E; Tuberculosis Vaccine Initiative, Lelystad, Netherlands; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. Electronic address: elly.vanriet@tbvi.eu., Corleis B; Institute of Immunology, Friedrich-Loeffler Institut, Insel Riems, Greifswald, Germany., Giersing BK; Department of Immunizations, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease & Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa., Burhan E; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia; Respiratory Programmatic Implementation and Research Institute, Jakarta, Indonesia., Jassat W; Tuberculosis Control and Management Cluster, National Department of Health, Pretoria, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., White RG; Tuberculosis Modelling Group, Tuberculosis Centre, Vaccine Centre, and Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK., Lewinsohn D; Department of Medicine, Oregon Health and Science University, Portland, OR, USA., Cobelens F; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2026 Jul; Vol. 26 (7), pp. e289-e301. Date of Electronic Publication: 2026 Mar 18. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41864213 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22van+Riet+E%22">van Riet E</searchLink>; Tuberculosis Vaccine Initiative, Lelystad, Netherlands; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. Electronic address: elly.vanriet@tbvi.eu.<br /><searchLink fieldCode="AU" term="%22Corleis+B%22">Corleis B</searchLink>; Institute of Immunology, Friedrich-Loeffler Institut, Insel Riems, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Giersing+BK%22">Giersing BK</searchLink>; Department of Immunizations, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hatherill+M%22">Hatherill M</searchLink>; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease & Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Burhan+E%22">Burhan E</searchLink>; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia; Respiratory Programmatic Implementation and Research Institute, Jakarta, Indonesia.<br /><searchLink fieldCode="AU" term="%22Jassat+W%22">Jassat W</searchLink>; Tuberculosis Control and Management Cluster, National Department of Health, Pretoria, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22White+RG%22">White RG</searchLink>; Tuberculosis Modelling Group, Tuberculosis Centre, Vaccine Centre, and Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Lewinsohn+D%22">Lewinsohn D</searchLink>; Department of Medicine, Oregon Health and Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Cobelens+F%22">Cobelens F</searchLink>; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2026 Jul; Vol. 26 (7), pp. e289-e301. <i>Date of Electronic Publication: </i>2026 Mar 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41864213 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1473-3099(26)00019-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e289 Titles: – TitleFull: Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van Riet E – PersonEntity: Name: NameFull: Corleis B – PersonEntity: Name: NameFull: Giersing BK – PersonEntity: Name: NameFull: Hatherill M – PersonEntity: Name: NameFull: Burhan E – PersonEntity: Name: NameFull: Jassat W – PersonEntity: Name: NameFull: White RG – PersonEntity: Name: NameFull: Lewinsohn D – PersonEntity: Name: NameFull: Cobelens F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1474-4457 Numbering: – Type: volume Value: 26 – Type: issue Value: 7 Titles: – TitleFull: The Lancet. Infectious diseases Type: main |
| ResultId | 1 |